What is the recommended treatment approach for a child with atopic dermatitis (eczema)?

Pediatric Eczema Treatment

All children with eczema should receive liberal emollient application at least twice daily (200-400g per week) combined with low-to-medium potency topical corticosteroids for active lesions, with treatment intensity escalated in a stepwise fashion based on disease severity. 1

Basic Foundation for All Severity Levels

Apply fragrance-free emollients liberally at least twice daily and immediately after a 10-15 minute lukewarm bath to lock in moisture when skin is most hydrated. 1 Ointments and creams are preferred for very dry skin or winter use. 1 Regular emollient use has both short-term and long-term steroid-sparing effects. 1, 2

Use a dispersible cream as a soap substitute instead of regular soap, as soaps and detergents remove natural lipid from the skin surface. 1 Keep nails short, dress children in cotton clothing next to skin, and avoid wool or synthetic fabrics. 1, 2

Stepwise Treatment Algorithm by Severity

Mild Eczema

Use reactive therapy with low-potency topical corticosteroids (hydrocortisone 1%) applied once or twice daily to affected areas for 3-7 days until lesions significantly improve. 1, 2 After the acute course, switch to proactive maintenance with twice-weekly applications on previously affected skin to prevent rebound flares. 2

Alternative options include pimecrolimus 1% cream (approved for children ≥3 months) or crisaborole (PDE-4 inhibitor, approved ≥3 months). 1 However, note that the FDA label indicates pimecrolimus is approved for children ≥2 years as second-line therapy. 3

Moderate Eczema

Use proactive and reactive therapy with low-to-medium potency topical corticosteroids (fluticasone or mometasone) applied once or twice daily during flares, then transition to twice-weekly maintenance on previously affected areas. 1, 2

For steroid-sparing options, use tacrolimus 0.03% ointment (approved ≥2 years) or pimecrolimus 1%, particularly valuable for facial eczema and sensitive areas including genital regions. 1, 2 Both calcineurin inhibitors avoid corticosteroid-related adverse effects such as skin atrophy and HPA-axis suppression. 2

Severe to Very Severe Eczema

Use medium-to-high potency topical corticosteroids for short periods (3-7 days maximum) on the body, combined with add-on systemic therapies for refractory cases. 1, 2

Add-on therapy options include:

• Dupilumab (approved for children ≥6 months with moderate-to-severe disease uncontrolled by topical agents), showing 69.7% EASI-75 improvement after 16 weeks. 2 Common adverse events include conjunctivitis, facial erythema, injection-site reactions, and herpes simplex infection. 2
• Cyclosporine, methotrexate, or azathioprine (off-label use). 1
• Phototherapy (not recommended for children <12 years). 1
• Short-course oral corticosteroids (<7 days) may be considered for severe acute flares, but recent evidence shows increased risk of serious adverse events even with brief exposure, and rebound flares are common after abrupt cessation. 1, 2

Location-Specific Guidance

Use only low-potency corticosteroids (hydrocortisone 1%) on the face, neck, and skin folds to avoid skin atrophy. 2, 4 For these sensitive areas, strongly consider topical calcineurin inhibitors as alternatives. 2, 4

Avoid medium, high, or ultra-high potency steroids in infants due to markedly increased risk of hypothalamic-pituitary-adrenal axis suppression from their high surface-area-to-volume ratio. 2

Managing Infectious Complications

If secondary bacterial infection is suspected (crusting, weeping, or worsening despite therapy), treat presumptively with oral flucloxacillin as first-line therapy for Staphylococcus aureus. 1, 2, 4 Avoid long-term topical antibiotics due to resistance and sensitization risk. 2

For eczema herpeticum (grouped, punched-out erosions or vesiculation indicating herpes simplex infection), initiate oral acyclovir promptly to prevent rapid systemic spread. 1, 2

Adjunctive Therapies

Sedating antihistamines may help short-term for sleep disturbance caused by nighttime itching, but non-sedating antihistamines have little value in atopic eczema. 2, 4 Wet wrap therapy or psycho-behavioral therapy can be considered for moderate to very severe disease. 1

Critical Pitfalls to Avoid

Do not continue daily topical corticosteroid application beyond 7 days without reassessment—transition to proactive twice-weekly maintenance instead of abrupt discontinuation to prevent rebound flares. 2, 4

Do not use potent or ultra-potent steroids as first-line therapy in infants or young children. 2 Provide only limited quantities with specific instructions on safe application sites and monitor for skin atrophy, striae, or signs of systemic absorption. 2

Consider poor treatment adherence or alternative diagnoses if treatment response is inadequate. 1, 4

Ineffective Therapies to Avoid

Evening primrose oil and borage oil have shown no benefit in two large trials and should not be recommended. 2, 4 Homeopathic remedies lack scientific evidence of efficacy. 2, 4 Chinese herbal medicines carry hepatotoxicity risk and require routine liver-function monitoring. 2, 4 Dietary elimination should be reserved only for cases with clear history of food-allergy-driven eczema or when first-line treatments have failed. 2, 4

When to Refer

Refer to a pediatric dermatologist when low-potency steroid therapy fails to achieve control within 1-2 weeks of appropriate use, when second-line topical agents are being considered, or when diagnostic uncertainty exists. 2